Review: Leukotriene-receptor antagonists are less effective than intranasal corticosteroids for allergic rhinitis

Li, James T.
September 2004
ACP Journal Club;Sep/Oct2004, Vol. 141 Issue 2, p45
Academic Journal
This article investigates that leukotriene receptor antagonists are less effective than antinasal corticosteroids for allergic rhinitis. In patients with allergic rhinitis, leukotrienereceptor antagonists did not differ from anti-histamines and were less effective than intranasal steroids in reducing nasal symptoms and improving rhinoconjunctivitis quality of life. All of the studies systematically reviewed by researchers evaluated the efficacy of montelukast in reducing symptom scores or improving quality of life scores in patients with seasonal allergic rhinitis.


Related Articles

  • Allergic rhinitis-induced nasal congestion: its impact on sleep quality. Storms, William // Primary Care Respiratory Journal;Mar2008, Vol. 17 Issue 1, p7 

    Allergic rhinitis (AR) is an extremely common health problem affecting 20 to 40 million Americans and between 10-25% of the world's population. Patients with AR suffer from both nasal symptoms (congestion, rhinorrhea, itching, and sneezing) and ocular symptoms (itching, redness, and tearing)....

  • Twenty-four-hour duration of effect of intranasal corticosteroids for seasonal allergic rhinitis symptoms: Clinical evidence and relevance. DuBuske, Lawrence M. // American Journal of Rhinology & Allergy;Jul/Aug2012, Vol. 26 Issue 4, p287 

    Background: Seasonal allergic rhinitis (SAR) symptoms are often most severe and/or disruptive during overnight and morning hours, resulting in cognitive/performance impairments and reduced quality of life throughout the following day. Surveys of allergy patients and health care practitioners...

  • Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys. Meltzer, Eli O.; Blaiss, Michael S.; Naclerio, Robert M.; Stoloff, Stuart W.; Derebery, M. Jennifer; Nelson, Harold S.; Boyle, John M.; Wingertzahn, Mark A. // Allergy & Asthma Proceedings;Sep/Oct2012 Supplement, Vol. 33 Issue 5, pS113 

    Allergic rhinitis (AR; also nasal allergies or "hay fever") is a chronic upper airway inflammatory disease that affects ~60 million adults and children in the United States. The duration and severity of AR symptoms contribute to a substantial burden on patients' quality of life (QoL), sleep,...

  • Intranasal Ciclesonide in Allergic Rhinitis. Vliagoftis, Harissios // Clinical Medicine Insights: Therapeutics;2010, Issue 2, p321 

    Allergic rhinitis affects more than 20% and is responsible for very high direct and indirect costs. Nasal corticosteroids are the principle pharmaceutical option for the treatment of allergic rhinitis. They are more effective than all other therapeutic options and in addition to improving...

  • Choosing between antihistamines and antileukotriene receptor antagonists. Kaliner, Michael // Patient Care for the Nurse Practitioner;Jun2005, Vol. 8 Issue 6, p4 

    The article looks at the effectivity of leukotriene receptor antagonists (LTRA) in reducing symptoms of allergic rhinitis. It offers information on the causes and nature of allergic rhinitis. The LTRA montelukast has been approved by the U.S. Food and Drug Administration for the treatment of...

  • Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents. Anolik, Robert; Pearlman, David; Teper, Ariel; Gates, Davis // Allergy & Asthma Proceedings;Jul/Aug2009, Vol. 30 Issue 4, p406 

    Seasonal allergic rhinitis (SAR) is common in adolescents. However, few studies have investigated the effectiveness of intranasal corticosteroids (INSs) for nasal and ocular symptoms of SAR solely in adolescents. The purpose of this study was to determine the safety and efficacy of the INS...

  • NOTHING TO SNEEZE AT. Crackel, Laura // Overdrive;Mar2005, Vol. 45 Issue 3, p22 

    Discusses the various medications suitable for drivers suffering from hay fever. Warning against the possible symptoms of sniffling, sneezing and watery eyes from pollen and seasonal allergens; Antihistamines; Nasal decongestants; Nasal corticosteroids; Eye drops; Saline nose drops.

  • Montelukast in the Treatment of Allergic Rhinitis. Nayaki, Anjuli; Langdon, Ronald B. // Drugs;2007, Vol. 67 Issue 6, p887 

    Cysteinyl-leukotrienes (CysLTs) are endogenous mediators of inflammation and play an important role in allergic airway disease by stimulating bronchoconstriction, mucus production, mucosal oedema and inflammation, airway infiltration by eosinophils, and dendritic cell maturation that prepares...

  • Nothing to Sneeze About.  // People's Medical Society Newsletter;Jun2001, Vol. 20 Issue 3, p4 

    Reports that corticosteroid nasal sprays are more potent than antihistamines in treating patients with allergic rhinitis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics